Trigemina, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2006-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.trigemina.com
TI-001 (Intranasal Oxytocin) for Treatment of High Frequency Episodic Migraine and Chronic Migraine
Phase 2
Completed
- Conditions
- High Frequency Episodic Migraine and Chronic Migraine
- Interventions
- Drug: Placebo
- First Posted Date
- 2013-04-24
- Last Posted Date
- 2016-05-13
- Lead Sponsor
- Trigemina, Inc
- Target Recruit Count
- 240
- Registration Number
- NCT01839149
© Copyright 2025. All Rights Reserved by MedPath